Healthcare at Home

Large enterpriseUK · LondonCompany No. 12253647

Healthcare at Home is a UK limited company, based in London, incorporated in 2019. Has won 41 UK public-sector contracts worth £136.0m across 16 buyers, primarily Berkshire Healthcare NHS Foundation Trust.

⇄ Compare peers ⇩ Export ↗ Share

Active contracts

no new awards in 30d

Contracted (12m)

—

no data

Public buyers

stable this month

Top buyer share

49%

Berkshire Healthcare NHS Foundation Trust

Buyer concentration

Each block sized by share of total award value. A dominant block signals dependency on one buyer.

High concentration. Top 3 buyers = 99% of revenue.

Berkshire Healthcare NHS Foundation Trust

£66.8m

49%

NHS England

£46.3m

34%

East Of England NHS Collaborative Hub

£21.4m

16%

University Hospitals of North Midlands NHS Trust

£1.1m

NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST

£500k

Contracts won · 41 total · 28 active · 13 expired

Every contract award published under the Procurement Act.

Sort

Title	Buyer	Award type	Value	Awarded	Status
Injectable Chemotherapy	Berkshire Healthcare NHS Foundation Trust	Shared contract	£66.7m lot total · 3 suppliers	29 Mar 2019	expired
NHS National framework agreement for the supply of home parenteral nutrition (HPN)	NHS England	Shared contract	£34.3m lot total · 7 suppliers	13 Feb 2020	expired
Homecare Medicines Services for Immunoglobulin Therapies	East Of England NHS Collaborative Hub	Framework call off	£16.7m ceiling · ~£2.8m share (÷6)	12 Jun 2020	expired
NHS Framework Agreement-Homecare treatment of Lysosomal Storage Disorders	NHS England	Shared contract	£8.0m lot total · 4 suppliers	01 Apr 2019	expired
Homecare Medicines Services	East Of England NHS Collaborative Hub	Framework call off	£4.7m ceiling · ~£293k share (÷16)	15 Aug 2017	expired
NHS National Framework Agreement Home Delivery Service Pulmonary Hypertension	NHS England	Framework call off	£2.4m ceiling · ~£480k share (÷5)	09 Mar 2020	expired
NHS National Framework agreement for the supply of Homecare Delivery Service - Products for the treatment of bleeding disorders in England, Wales and Northern Ireland	NHS England	Framework call off	£1.6m ceiling · ~£320k share (÷5)	20 Jun 2018	expired
HOME DELIVERY OF RECOMBINANT COAGULATION FACTORS FOR HAEMOPHILIA PATIENTS	University Hospitals of North Midlands NHS Trust	Direct contract	£1.1m	01 Jul 2017	expired
Provision of Patient Discharge Services	NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST	Direct contract	£500k	29 Dec 2021	expired
Purchasing, Dispesnsing and Delivery of Epoetins	Berkshire Healthcare NHS Foundation Trust	Shared contract	£83k lot total · 6 suppliers	17 Jul 2018	expired
Secondary Care Access and Discharge Services - AWARD	NOE CPC	Shared contract	— lot total · 10 suppliers	23 Dec 2020	expired
Parenteral Systemic Anti-Cancer Therapies and Other Biologicals Including Immunotherapies	DERBY TEACHING HOSPITALS NHS FOUNDATION TRUST	Framework call off	— ceiling · ~— share (÷3)	15 Mar 2019	expired
The Provision of Patient Discharge Services	N H S Shared Business Services	Shared contract	— lot total · 16 suppliers	18 Feb 2019	expired
Pharmacy Homecare Services - Low and Mid Tech	Royal Devon and Exeter NHS Foundation Trust	Shared contract	— lot total · 6 suppliers	—	active
NP30125 Homecare Delivery Service for Blood Clotting Factors	The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)	Shared contract	— lot total · 4 suppliers	—	active

Showing 1–15 of 41

Healthcare at Home

Buyer concentration

Contracts won · 41 total · 28 active · 13 expired

Top buyers · by total award value

Category mix — CPV divisions

Geographic spread

Modifications received · scope growth on existing wins

Compliance scorecard

Financial health

Company information

Corporate structure

Companies House data

Peer suppliers

News mentions

Compliance scorecard

Financial health

Company information

Corporate structure

Healthcare at Home

Companies House data

Why Capita's public-sector share keeps slipping — and who's eating it

The 12 frameworks Capita bid on last year (and lost 8)

Is BPO concentration back? A supplier-risk deep-dive